Buchumschlag

Pharmacological activation of pyruvate kinase M2 reprograms glycolysis leading to TXNIP depletion and AMPK activation in breast cancer cells

Aerobic glycolysis, discovered by Otto Warburg, is a hallmark of cancer metabolism even though not yet fully understood. The low activity of the cancerous pyruvate kinase isozyme (M2) is thought to play an important role by facilitating the conversion of glycolytic intermediates to other anabolic pa...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Almouhanna, Fadi (VerfasserIn) , Blagojević, Biljana (VerfasserIn) , Can, Suzan (VerfasserIn) , Ghanem, Ali (VerfasserIn) , Wölfl, Stefan (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 22 January 2021
In: Cancer & metabolism
Year: 2021, Jahrgang: 9, Heft: 1
ISSN:2049-3002
DOI:10.1186/s40170-021-00239-8
Online-Zugang:Verlag, kostenfrei, Volltext: https://doi.org/10.1186/s40170-021-00239-8
Verlag, kostenfrei, Volltext: https://cancerandmetabolism.biomedcentral.com/articles/10.1186/s40170-021-00239-8
Volltext
Verfasserangaben:Fadi Almouhanna, Biljana Blagojevic, Suzan Can, Ali Ghanem and Stefan Wölfl
Beschreibung
Zusammenfassung:Aerobic glycolysis, discovered by Otto Warburg, is a hallmark of cancer metabolism even though not yet fully understood. The low activity of the cancerous pyruvate kinase isozyme (M2) is thought to play an important role by facilitating the conversion of glycolytic intermediates to other anabolic pathways to support tumors’ high proliferation rate.
Beschreibung:Gesehen am 23.02.2021
Beschreibung:Online Resource
ISSN:2049-3002
DOI:10.1186/s40170-021-00239-8

Ähnliche Einträge